Mutations within the 5′ region of FAS/CD95 gene in nodal diffuse large B-cell lymphoma

Leukemia and Lymphoma

Volumn 48, Issue 5, 2007, Pages 957-963

  Scholl, Vanesa ^a,b   Stefanoff, Claudio Gustavo ^a,b   Hassan, Rocio ^a   Spector, Nelson ^b   Renault, Ilana Zalcberg ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

CD95; DLBCL; Nodal and extranodal lymphomas; Somatic hypermutation

Indexed keywords

FAS ANTIGEN;

5' UNTRANSLATED REGION; B CELL LYMPHOMA; CANCER GRADING; CONTROLLED STUDY; EXON; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC HYPERMUTATION; APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; LYMPH NODE METASTASIS; MOLECULAR GENETICS; MUTATION;

ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 34547398892     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701230858     Document Type: Review

References (36)

1. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G. and Klas, C. (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J Biol Chem, 267, pp. 10709-10715.
2. Smith, K. G., Nossal, G. J. and Tarlinton, D. M. (1995) Fas is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen. Proc Natl Acad Sci USA, 92, pp. 11628-11632.
3. Martinez-Valdez, H., Guret, C., de Bouteiller, O., Fugier, I., Banchereau, J. and Liu, Y. J. (1996) Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, p53 and Bax but not the survival gene bcl-2. J Exp Med, 183, pp. 971-977.
4. Landowski, T. H., Moscinski, L., Burke, R., Buyuksal, I., Painter, J. S. and Goldstein, S. (2001) CD95 antigen mutations in hematopoietic malignancies. Leuk Lymphoma, 42, pp. 835-846.
5. Lee, S. H., Shin, M. S., Park, W. S., Kim, S. Y., Dong, S. M. and Pi, J. H. (1999) Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder. Cancer Res, 59, pp. 3068-3072.
6. Takakuwa, T., Dong, Z., Takayama, H., Matsuzuka, F., Nagata, S. and Aozasa, K. (2001) Frequent mutations of Fas gene in thyroid lymphoma. Cancer Res, 61, pp. 1382-1385.
7. Wohlfart, S., Sebinger, D., Gruber, P., Buch, J., Polgar, D. and Krupitza, G. (2004) FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma. Am J Pathol, 164, pp. 1081-1089.
8. Muschen, M., Jungnickel, B., Diehl, V., Rajewsky, K. and Kuppers, R. (2000) Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J Exp Med, 192, pp. 1833-1840.
9. Boldrini, L., Faviana, P., Gisfredi, S., Quirico, D Di, Lucchi, M. and Mussi, A. (2002) Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer. Int J Oncol, 20, pp. 155-159.
10. Gronbaek, K., Straten, P. T., Ralfkiaer, E., Ahrenkiel, V., Andersen, M. K. and Hansen, N. E. (1998) Somatic Fas mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity. Blood, 92, pp. 3018-3024.
11. Muschen, M., Rajewsky, K., Krönke, M. and Küppers, R. (2002) The origin of CD95-gene mutations in B-cell lymphoma. Trends Immunol, 23, pp. 75-80.
12. Abramson, J. S. and Shipp, M. A. (2005) Advances in the biology and therapy of diffuse large B-cell lymphoma: Moving towards a molecularly targeted approach. Blood, 106, pp. 1164-1174.
13. Krol, A. D., Cessie, S le, Snijder, S., Kluin-Nelemans, J. C., Kluin, P. M. and Noordijk, E. M. (2003) Primary extranodal non-Hodgkin's lymphoma (NHL): The impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol, 14, pp. 131-139.
14. Moller, M. B., Pedersen, N. T. and Christensen, B. E. (2004) Diffuse large B-cell lymphoma: Clinical implications of extranodal versus nodal presentation-a population-based study of 1575 cases. Br J Haematol, 124, pp. 151-159.
15. Hans, C. P., Weisenburger, D. D., Greiner, T. C., Gascoyne, R. D., Delabie, J. and Ott, G. (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 103, pp. 275-282.
16. Jaffe, E. S., Harris, N. L., Stein, H. and Vardiman, J. W. (2001) World Health Organization Classification of Tumors. Pathology and genetics of tumours of hematopoietic and lymphoid tissues, IARC, Lyon
17. Stefanoff, C. G., Hassan, R., Gonzalez, A. C., Andrade, L. A., Tabak, D. G. and Romano, S. (2003) Laboratory strategies for efficient handling of paraffin-embedded tissues for molecular detection of clonality in non-Hodgkin lymphomas. Diagn Mol Pathol, 12, pp. 79-87.
18. Braggio, E., Bonvicino, C. R., Vargas, F. R., Ferman, S., LA Eisenberg, A. and Seuanez, H. N. (2004) Identification of three novel RB1 mutations in Brazilian patients with retinoblastoma by exon PCR mediated SSCP analysis. J Clin Pathol, 57, pp. 585-590.
19. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K. and Cleary, M. L. (1994) A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood, 84, pp. 1361-1392.
20. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Lossos, I. S. and Rosenwald, A. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, pp. 503-511.
21. Pileri, S. A., Dirnhofer, S., Went, P., Ascani, S., Sabattini, E. and Marafioti, T. (2002) Diffuse large B-cell lymphoma: One or more entities? Present controversies and possible tools for its subclassification. Histopathol, 41, pp. 482-509.
22. Lopez-Guillermo, A., Colomo, L., Jimenez, M., Bosch, F., Villamor, N. and Arenillas, L. (2005) Diffuse large B-cell lymphoma: Clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol, 23, pp. 2797-2804.
23. Seeberger, H., Starostik, P., Schwarz, S., Knörr, C., Kalla, J. and Ott, G. Loss of Fas (CD95/APO-1) regulatory function is an important step in early MALT- type lymphoma development. Lab Invest, 81, pp. 977-986.
24. Montesinos-Rongen, M., Van Roost, D., Schaller, C., Wiestler, O. D. and Deckert, M. (2004) Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. Blood, 103, pp. 1869-1875.
25. Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R. S. and Kuppers, R. (2001) Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature, 412, pp. 341-346.
26. Kramer, M. H., Hermans, J., Wijburg, E., Philippo, K., Geelen, E. and van Krieken, J. H. (1998) Clinical relevance of BCL2, BCL6 and MYC rearrangements in diffuse large B cell lymphoma. Blood, 92, pp. 3152-3162.
27. Rao, P. H., Houldsworth, J., Dyomina, K., Parsa, N. Z., Cigudosa, J. C. and Louie, D. C. (1998) Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood, 92, pp. 234-240.
28. Richardson, M. E., Chen, Q. G., Filippa, D. A., Offit, K., Hampton, A. and Koduru, P. R. (1987) Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes. Blood, 70, pp. 444-447.
29. Lossos, I. S. and Levy, R. (2000) Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the BCL-6 gene. Blood, 96, pp. 635-639.
30. Matolcsy, A., Casali, P., Warnke, R. A. and Knowles, D. M. (1996) Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene. Blood, 88, pp. 3937-3944.
31. Pinyol, M., Cobo, F., Bea, S., Jares, P., Nayach, I. and Fernandez, P. L. (1998) p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood, 91, pp. 2977-2984.
32. Lossos, I. S., Thorstenson, Y., Oefner, P. J. and Levy, R. (2003) Analysis of FAS (CD95) gene mutations in higher-grade transformation of follicle center lymphoma. Leuk Lymphoma, 4, pp. 1317-1323.
33. Shen, H. M., Peters, A., Baron, B., Zhu, X. and Storb, U. (1998) Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science, 280, pp. 1750-1752.
34. Pasqualucci, L., Migliazza, A., Fracchiolla, N., William, C., Neri, A. and Baldini, L. (1998) BCL-6 mutations in normal germinal center B cells: Evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA, 95, pp. 11816-11821.
35. Klein, U., Goossens, T., Fischer, M., Kanzler, H., Braeuninger, A. and Rajewsky, K. (1998) Somatic hypermutation in normal and transformed human B cells. Immunol Rev, 162, pp. 261-280.
36. Gordon, M. S., Kanegai, C. M., Doerr, J. R. and Wall, R. (2003) Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a). Proc Natl Acad Sci USA, 100, pp. 4126-4131.